School of Medicine
Showing 1-10 of 24 Results
-
Francois Haddad
Clinical Professor, Medicine - Cardiovascular Medicine
BioDr. Francois Haddad, MD is a Clinical Professor of Medicine that specializes in the field of cardio-vascular imaging, pulmonary hypertension, advanced heart failure and transplantation. Dr. Haddad has over 18 years of practice in the field of cardiology. He directs Stanford Cardiovascular Institute Biomarker and Phenotypic Core Laboratory dedicated to translational studies in cardiovascular medicine. The laboratory focuses on (1) identifying early biomarkers of heart failure and aging, (2) bioengineering approaches to cardiovascular disease modeling and (3) novel informatic approach for the detection and risk stratification of disease. He is involved is several precision medicine initiatives in health including the Project Baseline, the Integrated Personalized Omics Profiling Initiative, the Athletic screening program at Stanford and the Strong-D cardiac rehabilitation initiative in individuals with diabetes mellitus.
-
Christiane Haeffele
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Pediatrics - CardiologyCurrent Research and Scholarly InterestsAdult Congenital Heart Disease
-
Bereketeab Haileselassie
Assistant Professor of Pediatrics (Critical Care)
Current Research and Scholarly InterestsMy laboratory is focused on understanding the cellular mechanisms which mediate end-organ failure in pediatric sepsis. Our current work focuses on determining the role of altered mitochondrial dynamics in sepsis-induced multi-organ dysfunction syndrome (MODS). Specifically, we focus on understanding the mechanisms that mediate derangements in mitochondrial fission and autophagy in sepsis.
-
Frank Hanley
Lawrence Crowley, M.D., Endowed Professor of Child Health
Current Research and Scholarly InterestsHis research and clinical work focuses on the development of interventional techniques for fetal and neonatal treatment of congenital heart disease, pulmonary, vascular physiology, and the neurologic impact of open-heart surgery. He developed and pioneered the unifocalization procedure, in which a single procedure is used to repair a complex and life-threatening congenital heart defect rather than several staged open-heart surgeries as performed by other surgeons.
-
Robert Harrington
Arthur L. Bloomfield Professor of Medicine and Professor, by courtesy, of Health Policy
BioDr. Robert A. Harrington is a cardiologist and the Arthur L. Bloomfield Professor of Medicine and Chair of the Department of Medicine (DOM) at Stanford University. The DOM is the largest department at the Stanford School of Medicine with 14 divisions and more than 700 faculty.
He was previously the Richard Sean Stack, MD Distinguished Professor and the Director of the Duke Clinical Research Institute (DCRI) at Duke University. His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease; building local, national, and international collaborations for the efficient conduct of innovative clinical research; and trying to better understand and improve upon the methodology of clinical research, including the use of technologies to facilitate clinical trials.
He has authored more than 760 peer-reviewed manuscripts, reviews, book chapters, and editorials. He is a senior editor of the 13th and 14th editions of Hurst’s The Heart, one of the leading textbooks of cardiovascular medicine. He has served as a member and the chair of the US Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee.
Harrington is a member of the American Heart Association’s (AHA) Board of Directors. He served as AHA president-elect, president and immediate past president during 2019–2021. He is an elected member of the Association of American Physicians, the Association of University Cardiologists, and the National Academy of Medicine/Institute of Medicine. In 2016, he was named a Master of the American College of Cardiology. He was awarded the AHA’s Clinical Research Prize in 2017 and AHA Council on Clinical Cardiology (CLCD) Distinguished Achievement Award in 2022. In 2022, he was awarded the Stokes Medal from the Irish Cardiac Society.
Harrington received his BA in English at the College of the Holy Cross in Worcester, Massachusetts. He attended Dartmouth Medical School and received his MD from Tufts University School of Medicine in Boston. He did his internship and residency and served as the chief resident in internal medicine at the University of Massachusetts Medical Center in Worcester. He trained in cardiology, interventional cardiology, and clinical research (Duke Databank for Cardiovascular Disease) at Duke University Medical Center in Durham, North Carolina, where he was a faculty member from 1993–2012 before joining the Stanford University faculty in 2012.
Interested in innovative learning tools, Harrington can be followed on Twitter @HeartBobH and on a monthly podcast on theheart.org. -
E. John Harris Jr.
Professor of Surgery (Vascular), Emeritus
Current Research and Scholarly InterestsI am interested in thrombosis and the role of thrombin and its receptor in venous wall remodeling following venous thrombosis. I am also interested in vascular hemodynamics and the use of ultrasound, MRI and computational modeling in evaluating arterial flow in exercise conditions.
-
William Haskell
Professor (Research) of Medicine, Emeritus
Current Research and Scholarly InterestsMy major research interests and activities over the next several years will focus on the development and evaluation of the objective measurement of physical activity in free-living populations using a variety of sensing devices and mobile phones for data collection and processing. Also, I will continue to direct the Stanford Heart Network with the major mission being to assist community-based CVD prevention/treatment programs implement more effective heart attack and stroke prevention programs.
-
Paul Heidenreich, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsMy research interests include
1) The cost-effectiveness of new cardiovascular technologies.
Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.
2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.
3) Outcomes research using existing clinical and administrative datasets.
4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).
